Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-06 Sale | 2024-03-07 4:46 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 126,981 | $5.6 | $711,094 | 1,522,114 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:44 pm | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 34,811 | $5.6 | $194,942 | 495,928 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:43 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 40,665 | $5.51 | $224,064 | 584,072 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:42 pm | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 17,777 | $5.6 | $99,551 | 474,587 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:41 pm | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 57,745 | $5.6 | $323,372 | 443,824 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 4:11 pm | Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development | 4,930 | $6.1 | $30,073 | 319,128 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 4:35 pm | Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development | 25,146 | $5.48 | $137,800 | 324,058 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 4:33 pm | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 15,867 | $5.48 | $86,951 | 492,364 (Direct) | View |
| 2023-03-02 Sale(A) | 2024-02-22 4:19 pm | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 19,644 | $8.78 | $172,474 | 303,122 (Direct) | View |
| 2023-03-02 Sale(A) | 2024-02-22 4:17 pm | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 11,398 | $8.78 | $100,074 | 331,112 (Direct) | View |
| 2023-03-02 Sale(A) | 2024-02-22 4:15 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 33,047 | $8.78 | $290,153 | 982,671 (Direct) | View |
| 2023-05-23 Sale | 2023-05-23 5:19 pm | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 8,733 | $11.26 | $98,334 | 64,544 (Direct) | View |
| 2023-05-19 Sale | 2023-05-23 5:18 pm | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 272 | $10.58 | $2,878 | 11,961 (Direct) | View |
| 2023-05-23 Sale | 2023-05-23 5:17 pm | Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director | 4,650 | $11.26 | $52,359 | 48,627 (Direct) | View |
| 2023-05-23 Sale | 2023-05-23 5:16 pm | Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director | 4,818 | $11.26 | $54,251 | 39,459 (Direct) | View |
| 2023-05-23 Sale | 2023-05-23 5:14 pm | Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director | 4,815 | $11.26 | $54,217 | 33,762 (Direct) | View |
| 2023-03-02 Purchase | 2023-03-06 4:29 pm | Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director | 20,000 | $8.9142 | $178,284 | 70,000 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:29 pm | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 11,296 | $8.94 | $100,986 | 331,214 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:29 pm | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 19,402 | $8.94 | $173,454 | 303,364 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:27 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 32,750 | $8.94 | $292,785 | 982,968 (Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 4:04 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Internal Operations | 10,000 | $4.66 | $46,600 | 27,927 (Direct) | View |
| 2022-11-09 Purchase | 2022-11-14 4:31 pm | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 5,000 | $5.015 | $25,075 | 5,000 (Direct) | View |
| 2022-11-07 Purchase | 2022-11-09 4:05 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 30,000 | $5.16 | $154,800 | 89,512 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-20 Option Award | 2024-02-22 4:33 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 195,512 | $0 | 492,364 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:31 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 216,666 | $0 | 624,737 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 194,230 | $0 | 501,569 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:27 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 196,153 | $0 | 530,739 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:25 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 661,538 | $0 | 1,649,095 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-22 4:36 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Foster Robert T Director | 53,283 | $0 | 53,283 (Direct) | View |
| 2023-08-18 Option Award | 2023-08-21 4:25 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 46,872 | $0 | 46,872 (Direct) | View |
| 2023-08-18 Option Award | 2023-08-21 4:19 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 46,872 | $0 | 46,872 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:22 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director | 8,733 | $0 | 33,277 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-23 5:22 pm | N/A 2033-05-19 | Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director | 24,544 | $0 | 33,277 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:19 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 8,733 | $0 | 64,544 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-23 5:19 pm | N/A 2033-05-19 | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 24,544 | $0 | 64,544 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:18 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 8,733 | $0 | 11,961 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:17 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director | 8,733 | $0 | 48,627 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-23 5:17 pm | N/A 2033-05-19 | Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director | 24,544 | $0 | 48,627 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:16 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director | 8,733 | $0 | 78,733 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:16 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director | 8,733 | $0 | 39,459 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-23 5:16 pm | N/A 2033-05-19 | Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director | 24,544 | $0 | 39,459 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:14 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director | 8,733 | $0 | 33,762 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-23 5:14 pm | N/A 2033-05-19 | Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director | 24,544 | $0 | 33,762 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 271,134 | $0 | 403,141 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 229,421 | $0 | 331,214 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 204,810 | $0 | 303,364 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:28 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 107,202 | $0 | 259,162 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:28 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 170,188 | $0 | 312,719 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:28 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development | 191,462 | $0 | 344,274 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:27 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 667,407 | $0 | 982,968 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 4:13 pm | N/A 2032-08-01 | Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development | 409,704 | $0 | 409,704 (Direct) | View |